
Please try another search
Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju-si, South Korea.
Name | Age | Since | Title |
---|---|---|---|
Won Bong-hee | - | 2025 | Non-Executive Director |
Sang-woo Yang | - | - | Independent Non-Executive Director |
Tae-young Song | - | - | Independent Non-Executive Director |
Jin-Seok Seo | - | - | Joint Chairman of the Board |
Jung-Jin Seo | 68 | - | Joint Chairman of the Board |
Ryu Ho-Gil | - | 2025 | Independent Non-Executive Director |
Ahn Young-Gyun | - | 2025 | Independent Non-Executive Director |
Yoo Young-Ho | - | 2024 | CEO & Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review